{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:49:26Z","timestamp":1761821366062},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.intimp.2016.08.019","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T01:15:58Z","timestamp":1472087758000},"page":"11-15","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Polyclonal IgM and IgA block in vitro complement deposition mediated by anti-ganglioside antibodies in autoimmune neuropathies"],"prefix":"10.1016","volume":"40","author":[{"given":"Makoto","family":"Sudo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Miyaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Sp\u00e4th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Morita-Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Yuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2016.08.019_bb0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMcibr0803649","article-title":"The antiinflammatory IgG","volume":"359","author":"Kaveri","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2016.08.019_bb0010","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1073\/pnas.0807319106","article-title":"Impaired inhibitory Fc\u03b3 receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy","volume":"106","author":"Tackenberg","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2016.08.019_bb0015","first-page":"48","article-title":"Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies","volume":"8","author":"Vlam","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2016.08.019_bb0020","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2016.08.019_bb0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/jnnp.2010.205856","article-title":"IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy","volume":"82","author":"Yuki","year":"2011","journal-title":"J. Neurol. Nerosurg. Psychiatry"},{"key":"10.1016\/j.intimp.2016.08.019_bb0030","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1073\/pnas.97.3.1184","article-title":"Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM","volume":"97","author":"Boes","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2016.08.019_bb0035","first-page":"39","article-title":"High dose of intravenous immune globulin (IVIG) in the treatment of infantile spasms and Lennox-Gastaut syndrome","volume":"38","author":"Tyomin","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.intimp.2016.08.019_bb0040","doi-asserted-by":"crossref","first-page":"R213","DOI":"10.1186\/cc13028","article-title":"Early treatment with IgM-enriched intravenous immune globulin does not mitigate critical illness polyneuropathy and\/or myopathy in patients with multiple organ failure and SIRS\/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial","volume":"17","author":"Brunner","year":"2013","journal-title":"Crit. Care"},{"key":"10.1016\/j.intimp.2016.08.019_bb0045","article-title":"IgM-enriched human intravenous immunoglobulin-based treatment of patients with early donor specific anti-HLA antibodies after lung transplantation","author":"Ius","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.intimp.2016.08.019_bb0050","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1182\/blood.V93.3.942","article-title":"Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation","volume":"93","author":"Rieben","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.08.019_bb0055","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1046\/j.1365-3083.2000.00699.x","article-title":"Neutralization of disease associated autoantibodies by an immunoglobulin M- and immunoglobulin A-enriched human intravenous immunoglobulin preparation","volume":"51","author":"Bar-Dayan","year":"2000","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2016.08.019_bb0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0165-5728(96)00201-9","article-title":"Close association of Guillain\u2013Barr\u00e9 syndrome with antibodies to minor monosialogangliosides GM1b and GM1\u03b1","volume":"74","author":"Yuki","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2016.08.019_bb0065","doi-asserted-by":"crossref","first-page":"e107772","DOI":"10.1371\/journal.pone.0107772","article-title":"Different IVIG glycoforms affect in vitro inhibition of anti-ganglioside antibody-mediated complement deposition","volume":"9","author":"Sudo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2016.08.019_bb0070","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.autrev.2012.02.006","article-title":"Intravenous immunoglobulin: exploiting the potential of natural antibodies","volume":"11","author":"Kaveri","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2016.08.019_bb0075","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/eji.1830230402","article-title":"Expression and control of the natural autoreactive IgG repertoire in normal human serum","volume":"23","author":"Hurez","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2016.08.019_bb0080","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1182\/blood.V90.10.4004","article-title":"Pooled normal human polyspecific IgM contains neutralizing anti-idiotypes to IgG autoantibodies of autoimmune patients and protects from experimental autoimmune disease","volume":"90","author":"Hurez","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.08.019_bb0085","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-2249.2006.03098.x","article-title":"IgM-enriched human intravenous immunoglobulin suppresses T lymphocyte functions in vitro and delays the activation of T lymphocytes in hu-SCID mice","volume":"145","author":"Vassilev","year":"2006","journal-title":"Clin. Exp. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691630337X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691630337X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T13:59:49Z","timestamp":1601042389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757691630337X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":17,"alternative-id":["S156757691630337X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2016.08.019","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyclonal IgM and IgA block in vitro complement deposition mediated by anti-ganglioside antibodies in autoimmune neuropathies","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2016.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}